IPETX | VIVAX | IPETX / VIVAX | |
Total Expense Ratio | 1.09 | 0.17 | 641% |
Annual Report Gross Expense Ratio | 1.27 | 0.17 | 747% |
Fund Existence | 12 years | 33 years | - |
Gain YTD | 3.183 | 2.419 | 132% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 531M | 189B | 0% |
Annual Yield % from dividends | 1.48 | 2.16 | 69% |
Returns for 1 year | 5.70 | 8.01 | 71% |
Returns for 3 years | -48.39 | 32.20 | -150% |
Returns for 5 years | -35.10 | 72.56 | -48% |
Returns for 10 years | -42.00 | 103.54 | -41% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MLNSX | 25.56 | N/A | N/A |
Morgan Stanley Instl Glbl Concntr R6 | |||
TQVIX | 17.59 | -0.20 | -1.12% |
T. Rowe Price Integrated US LCV Eq I | |||
GHTMX | 15.00 | -0.18 | -1.19% |
Goldman Sachs International T/M Eq Instl | |||
PAULX | 41.95 | -0.54 | -1.27% |
T. Rowe Price US Large-Cap Core Adv | |||
TADAX | 28.59 | -0.43 | -1.48% |
Transamerica US Growth A |